CELL INTELLIGENCE · 肿瘤细胞治疗研究

表达新型嵌合抗原受体的体内编程髓系细胞在临床前实体瘤模型中显示强效抗肿瘤活性

In vivo programmed myeloid cells expressing novel chimeric antigen receptors show potent anti-tumor activity in preclinical solid tumor models.